AXXAM SPA has a total of 71 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are INCYTE SAN DIEGO INC, VERTEX PHARMACEUT INC and MEMORY PHARMACEUTICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 17 | |
#2 | Canada | 9 | |
#3 | China | 9 | |
#4 | WIPO (World Intellectual Property Organization) | 9 | |
#5 | United States | 8 | |
#6 | Australia | 5 | |
#7 | Israel | 5 | |
#8 | Republic of Korea | 4 | |
#9 | Hungary | 2 | |
#10 | Japan | 1 | |
#11 | Serbia | 1 | |
#12 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Pharmaceuticals | |
#4 | Agriculture | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Special acyclic compounds | |
#7 | Medical preparations | |
#8 | Analysing materials | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Pevarello Paolo | 29 |
#2 | Lohmer Stefan | 24 |
#3 | Corazza Sabrina | 22 |
#4 | Prandi Adolfo | 18 |
#5 | Cainarca Silvia | 15 |
#6 | Vitalone Rocco | 12 |
#7 | Nucci Cinzia | 12 |
#8 | Thomas Russell | 11 |
#9 | Pesenti Cristina | 10 |
#10 | Cusano Valentina | 10 |
Publication | Filing date | Title |
---|---|---|
EP3765446A1 | Substituted pyrazoles ffa4/gpr120 receptor agonists | |
EP3572792A1 | Apparatus and method for controlling light stimulation in in vitro testing and screening | |
EP3398941A1 | Heterocyclic p2x7 antagonists | |
EP3290417A1 | 2-chloro-n-[2-(1,3-thiazol-5-yl)ethyl]-5-(5-fluoropyrimidin-2-yl)-benzamides and their use as p2x7 receptor antagonists | |
EP3290416A1 | Substituted n-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and n-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives and their use as p2x7 receptor antagonist | |
EP2905282A1 | Substituted thiazole or oxazole as P2X7 receptor antagonists | |
EP1997885A1 | Fluorescent proteins and methods of use thereof | |
KR20080107353A | Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof | |
EP1908775A1 | Fluorescent proteins from the Ctenophora phylum and methods of use thereof | |
EP1808441A1 | Luminescent stem cells, transgenic mammals and uses thereof |